A detailed history of Xxec, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Xxec, Inc. holds 29,378 shares of ZTS stock, worth $4.8 Million. This represents 4.33% of its overall portfolio holdings.

Number of Shares
29,378
Previous 29,372 0.02%
Holding current value
$4.8 Million
Previous $5.09 Million 12.73%
% of portfolio
4.33%
Previous 3.93%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$172.58 - $196.48 $1,035 - $1,178
6 Added 0.02%
29,378 $5.74 Million
Q2 2024

Aug 09, 2024

BUY
$145.54 - $178.83 $4.27 Million - $5.25 Million
29,372 New
29,372 $5.09 Million
Q1 2024

Apr 22, 2024

BUY
$165.67 - $199.94 $828,349 - $999,700
5,000 Added 30.46%
21,417 $3.62 Million
Q4 2023

Jan 24, 2024

SELL
$151.44 - $200.09 $287,736 - $380,171
-1,900 Reduced 10.37%
16,417 $3.24 Million
Q3 2023

Nov 08, 2023

SELL
$167.14 - $192.77 $1.47 Million - $1.7 Million
-8,809 Reduced 32.47%
18,317 $3.19 Million
Q2 2023

Aug 02, 2023

BUY
$160.94 - $186.23 $4.37 Million - $5.05 Million
27,126 New
27,126 $4.67 Million
Q1 2023

May 08, 2023

BUY
$145.48 - $175.02 $4.09 Million - $4.92 Million
28,085 New
28,085 $4.67 Million
Q4 2022

Feb 02, 2023

SELL
$131.14 - $157.47 $110,682 - $132,904
-844 Reduced 1.47%
56,654 $8.3 Million
Q3 2022

Nov 04, 2022

SELL
$148.29 - $182.55 $163,415 - $201,170
-1,102 Reduced 1.88%
57,498 $8.53 Million
Q2 2022

Jul 26, 2022

SELL
$155.97 - $200.09 $352,336 - $452,003
-2,259 Reduced 3.71%
58,600 $10.1 Million
Q1 2022

Apr 12, 2022

BUY
$181.39 - $234.03 $1.69 Million - $2.19 Million
9,340 Added 18.13%
60,859 $12 Million
Q4 2021

Feb 02, 2022

SELL
$193.69 - $247.03 $5.45 Million - $6.95 Million
-28,117 Closed
0 $0
Q3 2021

Oct 19, 2021

BUY
$189.29 - $209.69 $5.32 Million - $5.9 Million
28,117 New
28,117 $5.46 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $76.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Xxec, Inc. Portfolio

Follow Xxec, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xxec, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xxec, Inc. with notifications on news.